8
$\begingroup$

Is working with and relying on old genome builds still valid?

For example NCBI36/hg18. Would results from papers based on old builds require LiftOver and re-analysis to be useful?

A bit of context, this is related to other post, where we have aCGH results based on old build: How do I validate a single sample ArrayCGH result?

$\endgroup$
1
  • $\begingroup$ This will be probably dependent what type of analysis you have in your mind. In the end, all the data we generate today will be one day obsolete, but it does not necessary mean that all the conclusions are wrong. If you would be more specific about types of analysis you have in your mind (or concrete papers using hg18), maybe it would be easier to give a correct answer. $\endgroup$ Jun 11, 2017 at 15:00

4 Answers 4

8
$\begingroup$

In my opinion, it is not very reliable. LiftOver is very limited in terms of transformations it can support. The LiftOver Chain format can capture only matching regions in the same order. It means that it can account for indels, but even simple structural variations become problematic.

For instance, when a newer assembly is available, it is usually a recommended practice to remap all the reads rather than transform the existing alignments.

$\endgroup$
4
$\begingroup$

I think that right now, the only human builds that are worth considering are hg19/GRCh37 as many data bases such as gnomAD still exclusively use this release. On the other hand, hg38/GRCh8 has many important fixes and the useful (but yet underused) feature of alternative loci.

Anything from older releases should be remapped to a more recent one.

$\endgroup$
2
$\begingroup$

You could use liftOver which isn't always great.

Whenever I encounter this (especially NGS data readily available on the SRA), I often just get the raw files (e.g. fastqs) and re-align/re-map.

In your case (arrays) it may be a bit tough. Not impossible though, as I recently took some old yeast DNA/RNA microarray data and updated it to the newest genome. Just requires the right data (like DNA for normalization) and a good understanding of the entire process.

A last resort/alternative is to align your new data to the old genome to be able to make comparisons. This isn't ideal but works in cases where upgrading one source isn't possible or is a HUGE amount of time/effort. I've done this for a few fly experiments where all the available/previous data was done in dm3. All the old genomes can generally be found on http://archive.ensembl.org .

$\endgroup$
0
$\begingroup$

For mouse, I still see people using mm9/NCBI37 in high profile publications even though mm10/GRCm38 was released more than 5 years ago (2011). I personally don't think that's a great idea, but it's certainly valid according to the peer reviewers.

It also depends on your application. If you are working with coding regions (likely well known for a long time) or extracting genome-wide stats (enrichment at TSS, for example), the differences should be negligible.

$\endgroup$

Your Answer

By clicking “Post Your Answer”, you agree to our terms of service and acknowledge that you have read and understand our privacy policy and code of conduct.

Not the answer you're looking for? Browse other questions tagged or ask your own question.